These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29887284)

  • 1. [Initial pharmacological treatment of the patient with heart failure with reduced systolic function: is the order of the initial and subsequent doses important?].
    Formiga F; Nuñez J
    Rev Esp Geriatr Gerontol; 2018; 53(4):183-184. PubMed ID: 29887284
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
    Grewal D; Partow-Navid R; Garcia D; Coney J; Fraser G; Stoletniy L; Sakr A; Parwani P; Abramov D
    Am J Cardiol; 2021 Jul; 151():64-69. PubMed ID: 34167690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.
    Tavazzi L; Maggioni AP; Borer JS
    Eur Heart J; 2013 Sep; 34(36):2792-4. PubMed ID: 23892200
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
    Ouwerkerk W; Zwinderman AH; Ng LL; Demissei B; Hillege HL; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Ter Maaten JM; Lang CC; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Voors AA
    J Am Coll Cardiol; 2018 Jan; 71(4):386-398. PubMed ID: 29389354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of spironolactone in heart failure patients receiving angiotensin-converting enzyme inhibitors and beta-blockers.
    Ahmed A
    J Am Coll Cardiol; 2003 May; 41(10):1851-2. PubMed ID: 12767683
    [No Abstract]   [Full Text] [Related]  

  • 6. A Stepwise Approach to the Management of Heart Failure and its Comorbidities.
    Rogers FJ; Saghir Z
    J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the target dose of neurohormonal blockade matter for outcome in Systolic heart failure in octogenarians?
    Barywani SB; Ergatoudes C; Schaufelberger M; Petzold M; Fu ML
    Int J Cardiol; 2015; 187():666-72. PubMed ID: 25880407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.
    Chin KL; Skiba M; Tonkin A; Reid CM; Liew D; Krum H; Hopper I
    Heart Fail Rev; 2016 Nov; 21(6):675-697. PubMed ID: 27465132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher medication doses in heart failure?
    McCormack J; McAlister FA; Kolber MR
    Can Fam Physician; 2017 Jan; 63(1):e20. PubMed ID: 28115456
    [No Abstract]   [Full Text] [Related]  

  • 11. [Male-female differences in the optimal dosage of medication for heart failure; the 'one-size-fits-all' approach to guidelines needs revision].
    Groenewegen A; Mosterd A; Rutten FH
    Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Bias in the Treatment of Chronic Systolic Heart Failure.
    Arfsten H; Goliasch G; Pavo N; Ulmer H; Hülsmann M; Stefenelli T;
    Ann Intern Med; 2020 Jan; 172(1):70-72. PubMed ID: 31569211
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic heart failure : current guideline recommendations and innovations].
    Ewen S; Mahfoud F; Böhm M
    Internist (Berl); 2015 Jul; 56(7):791-802. PubMed ID: 26088170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction.
    Driscoll A; Currey J; Tonkin AM
    JAMA Cardiol; 2016 Oct; 1(7):842-843. PubMed ID: 27556747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Care for Heart Failure With Reduced Ejection Fraction-A Potential Polypill-Based Strategy.
    Agarwal A; Yancy CW; Huffman MD
    JAMA; 2020 Dec; 324(22):2259-2260. PubMed ID: 33211084
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
    Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
    Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
    Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic systolic heart failure - dosing recommendations at beginning and end of treatment].
    Zugck C; Remppis A; Katus HA; Frankenstein L
    Ther Umsch; 2008 Oct; 65(10):585-92. PubMed ID: 18821517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
    Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.